Targeting transcriptional co-activators in advanced prostate cancer

Cell Cycle. 2016 Dec 16;15(24):3333-3334. doi: 10.1080/15384101.2016.1229019. Epub 2016 Sep 9.

Anna C Groner^{1

2}, Myles Brown^{1

2}, Jean-Philippe Theurillat^{3

4}

¹ a Department of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
² b Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
³ c Institute of Oncology Research, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland.
⁴ d Faculty of Biology and Medicine, Center Hospitalier, Universitaire Vaudois, University of Lausanne , Lausanne , Switzerland.

No abstract available

Keywords: Bromodomain; LXXLL motif; TRIM24; prostate cancer progression; targeting androgen receptor-mediated transcription.

Publication types